Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-02 09:18:24 UTC |
---|
Updated at | 2022-09-02 09:18:24 UTC |
---|
NP-MRD ID | NP0152761 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 8,10,17,20-tetrahydroxy-21-[(4-hydroxyphenyl)methyl]-1,3,4,6,13,15-hexamethyl-12-(2-methylpropyl)-18-(sec-butyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-7,16,19-triene-2,5,11,14-tetrone |
---|
Description | 18-(Butan-2-yl)-8,10,17,20-tetrahydroxy-21-[(4-hydroxyphenyl)methyl]-1,3,4,6,13,15-hexamethyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-7,16,19-triene-2,5,11,14-tetrone belongs to the class of organic compounds known as cyclic peptides. Cyclic peptides are compounds containing a cyclic moiety bearing a peptide backbone. It was first documented in 2022 (PMID: 36049892). Based on a literature review a significant number of articles have been published on 18-(butan-2-yl)-8,10,17,20-tetrahydroxy-21-[(4-hydroxyphenyl)methyl]-1,3,4,6,13,15-hexamethyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-7,16,19-triene-2,5,11,14-tetrone (PMID: 36049891) (PMID: 36049888) (PMID: 36049887) (PMID: 36049886) (PMID: 36049878) (PMID: 36049885). |
---|
Structure | CCC(C)C1N=C(O)C(CC2=CC=C(O)C=C2)N(C)C(=O)C(C)N(C)C(=O)C(C)N=C(O)CN(O)C(=O)C(CC(C)C)N(C)C(=O)C(C)N=C1O InChI=1S/C35H55N7O9/c1-11-20(4)29-31(46)37-22(6)33(48)41(10)27(16-19(2)3)35(50)42(51)18-28(44)36-21(5)32(47)39(8)23(7)34(49)40(9)26(30(45)38-29)17-24-12-14-25(43)15-13-24/h12-15,19-23,26-27,29,43,51H,11,16-18H2,1-10H3,(H,36,44)(H,37,46)(H,38,45) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C35H55N7O9 |
---|
Average Mass | 717.8650 Da |
---|
Monoisotopic Mass | 717.40613 Da |
---|
IUPAC Name | 18-(butan-2-yl)-8,10,17,20-tetrahydroxy-21-[(4-hydroxyphenyl)methyl]-1,3,4,6,13,15-hexamethyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-7,16,19-triene-2,5,11,14-tetrone |
---|
Traditional Name | 8,10,17,20-tetrahydroxy-21-[(4-hydroxyphenyl)methyl]-1,3,4,6,13,15-hexamethyl-12-(2-methylpropyl)-18-(sec-butyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-7,16,19-triene-2,5,11,14-tetrone |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC(C)C1N=C(O)C(CC2=CC=C(O)C=C2)N(C)C(=O)C(C)N(C)C(=O)C(C)N=C(O)CN(O)C(=O)C(CC(C)C)N(C)C(=O)C(C)N=C1O |
---|
InChI Identifier | InChI=1S/C35H55N7O9/c1-11-20(4)29-31(46)37-22(6)33(48)41(10)27(16-19(2)3)35(50)42(51)18-28(44)36-21(5)32(47)39(8)23(7)34(49)40(9)26(30(45)38-29)17-24-12-14-25(43)15-13-24/h12-15,19-23,26-27,29,43,51H,11,16-18H2,1-10H3,(H,36,44)(H,37,46)(H,38,45) |
---|
InChI Key | MIULAJWYSPXXSE-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cyclic peptides. Cyclic peptides are compounds containing a cyclic moiety bearing a peptide backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Cyclic peptides |
---|
Alternative Parents | |
---|
Substituents | - Cyclic alpha peptide
- Macrolactam
- Alpha-amino acid or derivatives
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Monocyclic benzene moiety
- Benzenoid
- Tertiary carboxylic acid amide
- Cyclic carboximidic acid
- Carboxamide group
- Hydroxamic acid
- Lactam
- Azacycle
- Polyol
- Organoheterocyclic compound
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organic oxygen compound
- Organopnictogen compound
- Organic nitrogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Xiang R, Li M, Gu Z, Liu H, Zeng H, Peng J: Chronic endometritis positively correlates with the aggravation of intrauterine adhesions but has limited effects on reproductive prognosis with antibiotic application. Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14434. [PubMed:36049892 ]
- Li M, Yue C: Abnormal uterine artery Doppler ultrasound during gestational 21-23 weeks associated with preeclampsia. Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14435. [PubMed:36049891 ]
- Meyer R, Weisz B, Eilenberg R, Tsadok MA, Uziel M, Sivan E, Mazaki-Tovi S, Tsur A: Utilizing Machine Learning to Predict Unplanned Cesarean Delivery. Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14433. [PubMed:36049888 ]
- Crockett C, Lorimer C: OncoFlash - Research Updates in a Flash! (September Edition). Clin Oncol (R Coll Radiol). 2022 Sep;34(9):551-553. doi: 10.1016/j.clon.2022.07.009. [PubMed:36049887 ]
- Authors unspecified: Corrigendum. Low Urin Tract Symptoms. 2022 Sep;14(5):405. doi: 10.1111/luts.12458. [PubMed:36049886 ]
- Sharma R, Huang Y, Dizdarevic A: Blood Conservation Techniques and Strategies in Orthopedic Anesthesia Practice. Anesthesiol Clin. 2022 Sep;40(3):511-527. doi: 10.1016/j.anclin.2022.06.002. Epub 2022 Jul 12. [PubMed:36049878 ]
- Beermann M, Jonsdottir G, Cronisoe A, Hasselrot K, Kopp Kallner H: Long term follow-up of uterine fibroids treated with microwave ablation: an up to 3-year observational study of volume, regrowth, and symptoms. Int J Hyperthermia. 2022;39(1):1158-1163. doi: 10.1080/02656736.2022.2109764. [PubMed:36049885 ]
- Al-Dadah O, Hing C: Patellofemoral instability. Knee. 2022 Aug;37:A1-A2. doi: 10.1016/j.knee.2022.07.015. [PubMed:36049884 ]
- Lirk P, Vlassakov K: Orthopedic Anesthesiology 2022. Anesthesiol Clin. 2022 Sep;40(3):xv-xvi. doi: 10.1016/j.anclin.2022.08.002. [PubMed:36049883 ]
- Fleisher LA: Orthopedic Anesthesiology: A Constantly Evolving Area of Perioperative Care. Anesthesiol Clin. 2022 Sep;40(3):xiii-xiv. doi: 10.1016/j.anclin.2022.08.001. [PubMed:36049882 ]
- Pean C, Weaver MJ, Harris MB, Ly T, von Keudell AG: What Do Orthopedic Trauma Surgeons Want and Expect from Anesthesiologists? Anesthesiol Clin. 2022 Sep;40(3):547-556. doi: 10.1016/j.anclin.2022.06.004. [PubMed:36049881 ]
- Vandepitte C, Van Pachtenbeke L, Van Herreweghe I, Gupta RK, Elkassabany NM: Same Day Joint Replacement Surgery: Patient Selection and Perioperative Management. Anesthesiol Clin. 2022 Sep;40(3):537-545. doi: 10.1016/j.anclin.2022.04.003. Epub 2022 Jul 12. [PubMed:36049880 ]
- Beloeil H: Opioid-Sparing Techniques in Orthopedic Anesthesia-One Step to Opioid-Free Anesthesia? Anesthesiol Clin. 2022 Sep;40(3):529-536. doi: 10.1016/j.anclin.2022.06.003. Epub 2022 Aug 6. [PubMed:36049879 ]
- Aguirre JA, Wolmarans M, Borgeat A: Acute Extremity Compartment Syndrome and (Regional): Anesthesia: The Monster Under the Bed. Anesthesiol Clin. 2022 Sep;40(3):491-509. doi: 10.1016/j.anclin.2022.06.001. Epub 2022 Aug 2. [PubMed:36049877 ]
- Alrayashi W, Cravero J, Brusseau R: Unique Issues Related to Regional Anesthesia in Pediatric Orthopedics. Anesthesiol Clin. 2022 Sep;40(3):481-489. doi: 10.1016/j.anclin.2022.05.001. Epub 2022 Jul 10. [PubMed:36049876 ]
- LOTUS database [Link]
|
---|